Abstract:Poly(ethylene glycol) (PEG) is extensively utilized in biomedical applications due to its biocompatibility; however, its thermal instability and susceptibility to oxidative degradation significantly constrain its long-term effectiveness. Zwitterionic polymers, characterized by their distinctive structure, enhanced stability, and superior biocompatibility, offer a more advantageous alternative. These polymers exhibit super hydrophilicity, resist nonspecific protein adsorption, and maintain stability in biological environments due to their charge-neutral ionic nature. Zwitterionic polymers enhance anticancer drug delivery by precisely targeting tumor cells and facilitating an efficient drug release. Their inherent antifouling properties and prolonged circulation within the bloodstream render them highly suitable for redox-sensitive drug carriers, thereby augmenting the antitumor efficacy. Moreover, zwitterionic polymers markedly mitigate biofouling in implants, biosensors, and wound dressings, thereby improving both their functionality and their therapeutic outcomes. These advantages arise from the formation of robust hydration layers, which significantly enhance the hemocompatibility and inhibit the adhesion of proteins, platelets, and bacteria. Zwitterionic polymers, including sulfobetaine (SB), phosphorylcholine (PC), and carboxybetaine (CB), are increasingly employed in blood-contacting devices and as effective coating materials for implantable devices. This mini-review paper aims to explore the recent diverse biomedical applications of zwitterionic polymers and highlight their advantageous properties compared with unmodified polymers. We will cover their use in drug delivery systems, tumor targeting nanocarriers, antibiofouling and antibacterial activities in implantable devices, tissue engineering, and diagnostic devices, demonstrating how their unique properties can translate into different applications. Through this exploration, this Perspective will display the potential of zwitterionic polymers as innovative polymer materials in the field of biomedical engineering and beyond.

Poly(N-Vinylpyrrolidone)-Modified Surfaces for Biomedical Applications

Biopolymer Coating for Particle Surface Engineering and Their Biomedical Applications

Poly(N-Vinylpyrrolidone)-Modified Surfaces Repel Plasma Protein Adsorption

New-Type Sulphonated Polymer Surfaces for Improving Blood Compatibility

Surface functionalization of polyurethanes: A critical review

Poly(N-Vinylpyrrolidone)-Modified Poly(Dimethylsiloxane) Elastomers As Anti-Biofouling Materials

Surface Functionalization of Polyurethane for Medicine and Blood Compatibility:Role of H_2O

P4VP Modified Zwitterionic Polymer for the Preparation of Antifouling Functionalized Surfaces.

Blood Compatibility of Biomaterial Surfaces Modified with PEG and Its Derivatives

Surface Functionalization of Poly(N-Vinylpyrrolidone) onto Poly(Dimethylsiloxane) for Anti-Biofilm Application

Biomimetic Hemo-compatible Surfaces of Polyurethane by Grafting Copolymer Brushes of Poly(ethylene glycol) and Poly(phosphorylcholine methacrylate)

Protein-resistant Properties of Poly(n-Vinylpyrrolidone)-modified Gold Surfaces: the Advantage of Bottle-Brushes over Linear Brushes.

Cytocompatibility of new-type sulfonated polymer surfaces

Insights into the Surface Property and Blood Compatibility of Polyethersulfone/polyvinylpyrrolidone Composite Membranes: Toward High-Performance Hemodialyzer

[Application of Polyvinyl Alcohol in Biomedical Engineering].

Zwitterionic Modification of Polyurethane Membranes for Enhancing the Anti-Fouling Property.

Functional Zwitterionic Polyurethanes: State‐of‐the‐Art Review

Surface Modification of Polypropylene Microfiltration Membranes by the Immobilization of Poly(n-Vinyl-2-pyrrolidone): a Facile Plasma Approach

Surface Modification for Nonspecific Protein Repelling and Specific Protein Binding

Zwitterionic Polymers for Biomedical Applications: Antimicrobial and Antifouling Strategies toward Implantable Medical Devices and Drug Delivery

Multifunctional Role of Polyvinylpyrrolidone in Pharmaceutical Formulations